Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for VectivBio Holding AG (VECT : NSDQ)
 
 • Company Description   
VectivBio Holding AG is a clinical stage biopharmaceutical company. It is focused on the discovery, development and commercialization of treatments for severe rare conditions for which there is a significant unmet medical need. VectivBio Holding AG is based in BASEL, Switzerland.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $6.55 Daily Weekly Monthly
20 Day Moving Average: 23,271 shares
Shares Outstanding: 34.01 (millions)
Market Capitalization: $222.80 (millions)
Beta:
52 Week High: $16.75
52 Week Low: $2.74
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 30.22% 46.65%
12 Week 13.91% 25.22%
Year To Date 33.40% 56.78%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
-
-
-,- -
-
ph: -
fax: -
None None
 
 • General Corporate Information   
Officers
- - -
- - -
- - -
- - -
- - -

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: H9060V101
SIC: -
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: 07/07/22
Share - Related Items
Shares Outstanding: 34.01
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $222.80 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-1.27 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-2.47 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 9.30% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/07/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - -
Quick Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - -
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - -
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©